Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis Academic Article uri icon


MeSH Major

  • Chromosomes, Human, Pair 16
  • Chromosomes, Human, Pair 8
  • Leukemia, Myeloid, Acute
  • Leukemia, Promyelocytic, Acute
  • Translocation, Genetic


  • Previous small series have suggested that acute myeloid leukemia with t(8;16) is a distinct morphologic and clinical entity associated with poor prognosis. We describe 18 patients with t(8;16) AML, including their clinical, cytomorphologic, immunophenotypic and cytogenetic features. Half of the patients had extramedullary disease, most commonly leukemia cutis, which often preceded bone marrow involvement and six had therapy-related AML. Patients with t(8;16) AML commonly present with clinical and pathological features that mimic APL, with promyelocytes and promyeloblast-like cells and coagulopathy in most patients. Several patients also presented with marrow histiocytes with hemophagocytosis and erythrophagocytosis. Comprehensive molecular analysis for co-occurring genetic alterations revealed a somatic mutation in RUNX1 in 1 of 6 t(8;16) patients with no known AML mutation in the remaining five t(8;16) patients. This suggests that the t(8;16) translocation could be sufficient to induce hematopoietic cell transformation to AML without acquiring other genetic alteration. These data further support classifying t(8;16) AML as a clinically and molecularly defined subtype of AML marked by characteristic clinical and cytomorphologic features that mimic APL, and is associated with very poor survival.

publication date

  • January 2013



  • Academic Article



  • eng

PubMed Central ID

  • PMC5382928

Digital Object Identifier (DOI)

  • 10.1016/j.leukres.2012.08.025

PubMed ID

  • 23102703

Additional Document Info

start page

  • 32

end page

  • 6


  • 37


  • 1